Download the PDF below! 

Postbiotics are currently enjoying a surge in popularity among consumers and formulators alike, thanks to their significant benefits for gut and immune support as well as their ability to withstand various manufacturing challenges associated with live microorganisms. That said, not all postbiotics are equal. “Each postbiotic is unique based on the microorganisms, fermentation medium and method used, and post-fermentation process,” explained Justin Green, director of scientific affairs at EpiCor, a Cargill brand. What distinguishes EpiCor^® postbiotic, a whole-food fermented postbiotic, from category competitors is the extensive track record, robust scientific support and manufacturing expertise behind it.

EpiCor postbiotic stands out as a whole-food, fermented ingredient derived from Saccharomyces cerevisiae (baker’s yeast). It is manufactured in a dedicated state-of-the-art facility in Ankeny, Iowa meeting stringent dietary supplement current good manufacturing practices (cGMPs). EpiCor boasts a low efficacious dose of 500 mg per day, is highly heat stable, can handle varying pH levels, and has a three-year shelf life from its manufacture date. “EpiCor contains a beneficial mix of metabolites and numerous other health-enhancing bioactive compounds,” Green added. “It’s also the No. 1 selling postbiotic on the market and has been integrated into more dietary supplement products than any other postbiotic.”

Since 2006, more than 15 published studies (including eight human clinical trials) have confirmed the safety and efficacy of EpiCor.

Some of the earliest studies on EpiCor focused on its immune system response, with one study finding statistically significant increases in immune markers within just two hours of ingesting one 500 mg dose.¹ Subsequent research found that EpiCor may help support the immune system and alleviate seasonal nasal symptoms.²

Building on this foundation, additional scientific studies have focused on EpiCor's potential to directly support gut health. These studies suggest EpiCor supports positive changes in the gut’s microbial community,³ but it has also shown promise for reducing bloating, feelings of fullness, and overall digestive discomfort in subjects with occasional stomach upset and constipation.⁴ “While there is still much to learn about the gut-immune connection, research findings like these highlight what I see as EpiCor’s overarching benefit—helping people live more healthy days,” said Green.

Beyond its health benefits, EpiCor boasts versatility across different formulations, from gummies to ready-to-drink functional beverages. Unlike probiotics (which must be “alive” to benefit the body), postbiotics do not require viability to be effective. As a result, EpiCor is appropriate for a range of products where probiotics aren’t suitable—for example, environments with moisture or in products requiring extended shelf life.

This PDF was paid for and provided by EpiCor Postbiotics (a Cargill brand)

These statements have not been evaluated by competent food authorities. The product is not intended to diagnose, treat, cure, or prevent any disease. 

Find citations here